| Literature DB >> 31185411 |
Samuel Golten1, Allan Patinec2, Katy Akoumany1, Jézabel Rocher2, Jérôme Graton1, Denis Jacquemin1, Jean-Yves Le Questel1, Arnaud Tessier1, Jacques Lebreton1, Virginie Blot1, Muriel Pipelier1, Jean-Yves Douillard3, Jacques Le Pendu2, Bruno Linclau4, Didier Dubreuil5.
Abstract
iNKT cells recognize CD1d/α-galactosylceramide (α-GalCer) complexes via their invariant TCR receptor and stimulate the immune response. Many α-GalCer analogues have been investigated to interrogate this interaction. Following our previous work related to the modification of the hydrogen bond network between α-GalCer and CD1d, we have now focused our attention on the synthesis of 3-deoxy-3,3-difluoro- and 3,4-dideoxy-3,3,4,4-tetrafluoro-α-GalCer analogues, and studied their ability to stimulate human iNKT cells. In each case, deoxygenation at the indicated positions was accompanied by difluoro introduction in order to evaluate the resulting electronic effect on the stability of the ternary CD1d/Galcer/TCR complex which has been rationalized by modeling study. With deoxy-difluorination at the 3-position, the two epimeric 4-OH analogues were investigated to establish their capacity to compensate for the lack of the hydrogen bond donating group at the 3-position. The 3,4-dideoxytetrafluoro analogue was of interest to highlight the amide NH-bond hydrogen bond properties.Entities:
Keywords: Fluoro GalCer analogues; Immune response; Modeling study; iNKT activation
Mesh:
Substances:
Year: 2019 PMID: 31185411 DOI: 10.1016/j.ejmech.2019.05.069
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514